Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

FDA Approves Rituximab for Children with GPA & MPA

Michele B. Kaufman, PharmD, BCGP  |  October 23, 2019

Intravenous rituximab can now be used to treat pediatric patients with GPA and MPA as young as two years old…

Filed under:Drug Updates Tagged with:giant cell arteritis (GCA)GPAmicroscopic polyangiitis (MPA)rituximabVasculitis

Lightspring / shutterstock.com

Why You Should Consider Adding a Dietitian to Your Team

Linda Childers  |  October 18, 2019

A patient with rheumatoid arthritis (RA) asks if diet can help ease their symptoms. Or maybe a patient with severe knee osteoarthritis (OA) seeks diet advice because they want to lose weight and relieve pressure on their joints. Although there’s no specific nutrition plan for patients with rheumatic diseases, research has shown many dietary factors…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)Dietdietitian

Study Implicates Epstein-Barr Virus in 7 Autoimmune Diseases

Mary Beth Nierengarten  |  October 18, 2019

The identification of specific transcription factors linked to the Epstein-Barr virus (EBV) provides new information on the molecular mechanisms underlying the link between EBV and autoimmune disease. A recently published study, “Transcrip­tion Factors Operate Across Disease Loci, with EBNA2 Implicated in Auto­immunity,” co-led by John B. Harley, MD, PhD; Leah C. Kottyan, PhD; and Matthew…

Filed under:ConditionsResearch Rheum Tagged with:Epstein-Barr virus (EBV)

Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

Stephanie Kydd Dondero, DO, & Barry Waters, MD  |  October 18, 2019

Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immuno­modulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine mono­phosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

Filed under:Conditions Tagged with:apremilastcase reportimmunosuppressive drugsStreptococcus salivarius

Annual Meeting Preview: Effective Advocacy By & For ACR/ARP Members

Mary Beth Nierengarten  |  October 3, 2019

Session attendees will hear about recent successes from the Government Affairs Committee and learn how to become effective rheumatology advocates.

Filed under:Meeting Reports Tagged with:2019 ACR/ARP Annual MeetingAdvocacyGovernment Affairs Committee

Innovative Education Formats & More: What’s New at the 2019 ACR/ARP Annual Meeting

From the College  |  October 3, 2019

With innovative session formats and unique spaces that encourage learning and networking, the 2019 ACR/ARP Annual Meeting will offer exciting new opportunities for rheumatology professionals. Here’s a sneak peek…

Filed under:Education & TrainingProfessional Topics Tagged with:2019 ACR/ARP Annual MeetingCareerEducation

Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes

Kelly Tyrrell  |  September 20, 2019

Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.

Filed under:Legislation & Advocacy Tagged with:Advocacy 101Advocates for ArthritisRheumPAC

National Survey Highlights Rheumatology Patient Concerns, Challenges

Susan Bernstein  |  September 20, 2019

In a national survey of more than 1,500 Americans with rheumatic disease, more than half reported struggling to access affordable care and nearly two-thirds described challenges performing simple daily tasks.

Filed under:Patient Perspective Tagged with:patient perspectiveRheumatic Disease Awareness MonthSimple Tasks

How to Cultivate Stronger Mentor–Mentee Relationships

Carina Stanton  |  September 17, 2019

An experienced mentor shares his tips for how to support rheumatology professionals who are learning the art of rheumatologic care early in their careers…

Filed under:Career DevelopmentProfessional Topics Tagged with:CareerMentoringMentorshipprofessionalprofessional development

AJPhoto / Science Source

Tips for Diagnosing Metabolic Myopathies

Ruth Jessen Hickman, MD  |  September 17, 2019

When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

Filed under:Conditions Tagged with:creatinine kinesegenetic diseasegenetic disordersMetabolic Myopathiesrhabdomyolysis

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences